NHBSENarayana Hrudayalaya LtdMinimalNeutral
Announced Sun, 24 May · 23:04 IST

Copy of newspaper publication of the audited (Standalone and consolidated) financial results of the company for the quarter and year ended March 31 2026

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1848.30
prior close
₹1930.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.7+0.2+0.4+2.7+4.1+5.0+3.2+4.3+5.8+0.8+5.6+11.1
Up moveDown movePending
AI summary

Narayana Hrudayalaya (Narayana Health) published its audited FY2026 results. Standalone total income grew 34% to ₹41,516 million with net profit up 66% to ₹5,031 million. Consolidated income surged 64% to ₹79,963 million with net profit doubling to ₹10,253 million. Standalone operating margin was 21.12% and net profit margin was 12.12%. The strong consolidated growth reflects contributions from subsidiaries. Q4 standalone profit of ₹2,642 million implies the fourth quarter contributed over half of full-year earnings, indicating a seasonally strong finish. Reserves grew to ₹43,329 million on consolidated basis.

Likely market impact

Strong double-digit growth across all key metrics with net profit roughly doubling year-over-year. The consolidated results significantly outperformed standalone, suggesting improving scale and diversification. High valuations apply given the premium healthcare sector positioning.